The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease.
134
mentions
- X 89
- News 29
- Blogs 6
- Facebook 4
- +3 more
Kristin Varhaug
PubHawk tracks social media discussions for 1 article by authors named Kristin Varhaug.
Mentions
134
Peak: 64 in Mar 2022
across 1 tracked article
Extended reach
740,371
potential audience
Total likes
296
Video views
1,763
Mentions per month
Mar 2022 – Aug 2025Where it's discussed
-
X / Twitter89 posts
-
News29 articles
-
Blogs6 articles
-
Facebook4 posts
-
Reddit4 posts
-
Bluesky1 posts
-
YouTube1 videos
Tracked by PubHawk
Most discussed articles
From PubMed
All publications
Searching PubMed…